T-helper 2 involvement in the pathogenesis of bullous pemphigoid: Role of soluble CD30 (sCD30)

Archives of Dermatological Research

Volumn 289, Issue 12, 1997, Pages 667-670

  De Pita O ^a   Frezzolini, A ^a   Cianchini, G ^a   Ruffelli, M ^a   Teofoli, P ^a   Puddu, P ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Bullous pemphigoid; Interleukin 4; sCD30; T helper 2

Indexed keywords

CD30 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; DRUG EFFICACY; FEMALE; HELPER CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; MALE; PATHOGENESIS; PEMPHIGOID; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

AGED; ANTIGENS, CD30; CASE-CONTROL STUDIES; EVALUATION STUDIES; FEMALE; HUMANS; INTERLEUKIN-4; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; SOLUBILITY; T-LYMPHOCYTES, HELPER-INDUCER; TH2 CELLS;

EID: 0031455476     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050259     Document Type: Article

References (27)

1. Ahmed AR, Maize JC, Provost TT (1977) Bullous pemphigoid: clinical and immunologic follow-up after successful therapy. Arch Dermatol 113:1043-1046
2. Jordon RE, Beutner EH, Witebsky E, Blumenthal G, Hale WL, Lever WF (1967) Basement membrane zone antibodies in bollous pemphigoid. JAMA 200:751-756
3. Ambach A, Zillikens D, Klingen B, Hartmann AA, Burg G (1991) Characterization of the mononuclear infiltrate in bullous pemphigoid. Hautarzt 43:81-85
4. Nestor MS, Cochran AJ, Ahmed AR (1987) Mononuclear cell infiltrates in bollous disease. J Invest Dermatol 88:172-175
5. Kaneko F, Minagawa T, Takiguchi Y, Suzuki M, Itoh N (1992) Role of cell-mediated immune reaction in blister formation of bullous pemphigoid. Dermatology 184:34-39
6. Schaller J, Haustein UF, Fiebig H (1987) T-Helper cell activation in bullous pemphigoid. Acta Derm Venereol 67:520-523
7. Schmidt E, Mittnacht A, Schömig H, Dummer R, Bröcker E, Zillikens D (1996) Detection of IL1-α, IL-1β and IL-1 receptor antagonist in blister fluid of bullous pemphigoid. J Dermatol Sci 11:142-147
8. Zillikens D, Schuessler M, Dummer R, Porzsolt F, Hartmann AA, Burg G (1992) Tumor necrosis factor in blister fluids of bullous pemphigoid. Eur J Dermatol 2:429-431
9. Tamaki K, So K, Furuya T, Furue M (1994) Cytokine profile of patients with bullous pemphigoid. Br J Dermatol 130:128-129
10. Schmidt E, Ambach A, Bastian B, Bröcker E, Zillikens D (1996) Elevated levels of interleukin-8 in blister fluid of bullous pemphigoid compared with suction blister of healthy control subjects. J Am Acad Dermatol 34:310-312
11. Schmidt E, Bastian B, Dummer R, Tony H, Bröcker E, Zillikens D (1996) Detection of elevated levels of IL-4, IL-6 and IL-10 in blister fluid of bullous pemphigoid. Arch Dermatol Res 288:353-357
12. Jeffes T, Ahmed AR, Granger M (1984) Lymphotoxin detected in blister fluids of bullous pemphigoid. J Clin Immunol 4:31-35
13. Ahmed AR, Higri K, Arab-Kemani V (1984) Interleukin-2 production in bullous pemphigoid. Arch Dermatol Res 276:330-332
14. Endo H, Iwamoto I, Fujita M, Okamoto S, Yoshida S (1992) Increased immunoreactive interleukin-5 levels in blister fluid of bullous pemphigoid. Arch Dermatol Res 284:312-314
15. Czech W, Schaller J, Schopf E, Kapp A (1993) Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris. J Am Acad Dermatol 29:210-215
16. Caproni M, Palleschi GM, Falcos D, D'Agata A, Cappelli G, Fabbri P (1995) Serum eosinophil cationic protein (ECP) in bullous pemphigoid. Int J Dermatol 34:177-180
17. Maekawa N, Hosokawa H, Soh H, Kasaharu M, Izumi H, Yodoi J, Asada Y (1995) Serum levels of soluble CD23 in patients with bullous pemphigoid. J Dermatol 22:310-315
18. Schmidt E, Brocker EB, Zillikens D (1995) High levels of soluble CD23 in blister fluid of patients with bullous pemphigoid. Arch Dermatol 131:966-967
19. Zillikens D, Ambach A, Schuessler M, Dummer R, Hartmann A, Burg G (1992) The interleukin-2 receptor in lesions and serum of bullous pemphigoid. Arch Dermatol Res 284:141-145
20. Mosmann TR, Coffman RL (1989) Th1 and Th2 cells: different pattern of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173
21. Romagnani S, Del Prete G, Maggi E, Chilosi M, Caligaris-Cappio F, Pizzolo G (1995) CD30 and type 2 helper (Th2) responses. J Leuk Biol 57:726-730
22. + T cells producing Th2-type cytokines. FASEB J 9:81-86
23. Del Prete G, Maggi E, Pizzolo G, Romagnani S (1995) CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol Today 16(2):76-80
24. Zillikens D, Schmidt E, Depprich R, Dummer R, Zentner A, Brocker EB (1994) Contribution of cytokines to blister formation in bullous pemphigoid (abstract). Arch Dermatol Res 286: 200
25. Fattovich G, Vinante F, Giustina G, Morosato L, Alberti A, Ruol A. Pizzolo G (1996) Serum levels of soluble CD30 in chronic hepatitis B virus infection. Clin Exp Immunol 103: 105-110
26. Chilosi M, Facchetti F, Notarangelo LD, Romagnani S, Del Prete G, Almerigogna F, De Carli M, Pizzolo G (1996) CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition. Eur J Immunol 26:329-334
27. Frezzolini A, Paradisi M, Ruffelli M, Cadoni S, De Pitá O (1997) Soluble CD30 in pediatric patients with atopic dermatitis. Allergy 52:106-109